Molecular Psychiatry Molecular Psychiatry publishes work aimed at elucidating biological mechanisms underlying psychiatric disorders and their treatment. The emphasis is on studies at the interface of pre-clinical and clinical research, including studies at the cellular, molecular, integrative, clinical, imaging and psychopharmacology levels. In addition to Original Articles, the journal features News &amp; Commentary, Reviews, and Immediate Communications. http://feeds.nature.com/mp/rss/current Nature Publishing Group en © 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. Molecular Psychiatry © 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. permissions@nature.com Molecular Psychiatry https://www.nature.com/uploads/product/mp/rss.gif http://feeds.nature.com/mp/rss/current <![CDATA[Sex dimorphism controls dysbindin-related cognitive dysfunctions in mice and humans with the contribution of COMT]]> https://www.nature.com/articles/s41380-024-02527-3 Molecular Psychiatry, Published online: 26 March 2024; doi:10.1038/s41380-024-02527-3

Sex dimorphism controls dysbindin-related cognitive dysfunctions in mice and humans with the contribution of COMT]]>
Federica GeraciRoberta PassiatoreNora PenzelSamuele LaudaniAlessandro BertolinoGiuseppe BlasiAdriana C. E. GrazianoGianluca C. KikidisCiro MazzaMadhur PariharAntonio RampinoLeonardo SportelliNicolò TrevisanFilippo DragoFrancesco PapaleoFabio SambataroGiulio PergolaGian Marco Leggio doi:10.1038/s41380-024-02527-3 Molecular Psychiatry, Published online: 2024-03-26; | doi:10.1038/s41380-024-02527-3 2024-03-26 Molecular Psychiatry 10.1038/s41380-024-02527-3 https://www.nature.com/articles/s41380-024-02527-3
<![CDATA[Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?]]> https://www.nature.com/articles/s41380-024-02539-z Molecular Psychiatry, Published online: 26 March 2024; doi:10.1038/s41380-024-02539-z

Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?]]>
Song ChenYunlong TanLi Tian doi:10.1038/s41380-024-02539-z Molecular Psychiatry, Published online: 2024-03-26; | doi:10.1038/s41380-024-02539-z 2024-03-26 Molecular Psychiatry 10.1038/s41380-024-02539-z https://www.nature.com/articles/s41380-024-02539-z
<![CDATA[Chronometric TMS-fMRI of personalized left dorsolateral prefrontal target reveals state-dependency of subgenual anterior cingulate cortex effects]]> https://www.nature.com/articles/s41380-024-02535-3 Molecular Psychiatry, Published online: 26 March 2024; doi:10.1038/s41380-024-02535-3

Chronometric TMS-fMRI of personalized left dorsolateral prefrontal target reveals state-dependency of subgenual anterior cingulate cortex effects]]>
Sarah GrosshagauerMichael WoletzMaria VasileiadiDavid LinhardtLena NohavaAnna-Lisa SchulerChristian WindischbergerNolan WilliamsMartin Tik doi:10.1038/s41380-024-02535-3 Molecular Psychiatry, Published online: 2024-03-26; | doi:10.1038/s41380-024-02535-3 2024-03-26 Molecular Psychiatry 10.1038/s41380-024-02535-3 https://www.nature.com/articles/s41380-024-02535-3
<![CDATA[Serotonin effects on human iPSC-derived neural cell functions: from mitochondria to depression]]> https://www.nature.com/articles/s41380-024-02538-0 Molecular Psychiatry, Published online: 26 March 2024; doi:10.1038/s41380-024-02538-0

Serotonin effects on human iPSC-derived neural cell functions: from mitochondria to depression]]>
Iseline CardonSonja GrobeckerFrederike JenneTatjana JahnerRainer RupprechtVladimir M. MilenkovicChristian H. Wetzel doi:10.1038/s41380-024-02538-0 Molecular Psychiatry, Published online: 2024-03-26; | doi:10.1038/s41380-024-02538-0 2024-03-26 Molecular Psychiatry 10.1038/s41380-024-02538-0 https://www.nature.com/articles/s41380-024-02538-0
<![CDATA[Transcriptomic dysregulation and autistic-like behaviors in <i>Kmt2c</i> haploinsufficient mice rescued by an LSD1 inhibitor]]> https://www.nature.com/articles/s41380-024-02479-8 Molecular Psychiatry, Published online: 26 March 2024; doi:10.1038/s41380-024-02479-8

Transcriptomic dysregulation and autistic-like behaviors in Kmt2c haploinsufficient mice rescued by an LSD1 inhibitor]]>
Kmt2c haploinsufficient mice rescued by an LSD1 inhibitor]]> Takumi NakamuraToru YoshiharaChiharu TanegashimaMitsutaka KadotaYuki KobayashiKurara HondaMizuho IshiwataJunko UedaTomonori HaraMoe NakanishiToru TakumiShigeyoshi ItoharaShigehiro KurakuMasahide AsanoTakaoki KasaharaKazuo NakajimaTakashi TsuboiAtsushi TakataTadafumi Kato doi:10.1038/s41380-024-02479-8 Molecular Psychiatry, Published online: 2024-03-26; | doi:10.1038/s41380-024-02479-8 2024-03-26 Molecular Psychiatry 10.1038/s41380-024-02479-8 https://www.nature.com/articles/s41380-024-02479-8
<![CDATA[Active forgetting and neuropsychiatric diseases]]> https://www.nature.com/articles/s41380-024-02521-9 Molecular Psychiatry, Published online: 26 March 2024; doi:10.1038/s41380-024-02521-9

Active forgetting and neuropsychiatric diseases]]>
Jacob A. BerryDana C. GuhleRonald L. Davis doi:10.1038/s41380-024-02521-9 Molecular Psychiatry, Published online: 2024-03-26; | doi:10.1038/s41380-024-02521-9 2024-03-26 Molecular Psychiatry 10.1038/s41380-024-02521-9 https://www.nature.com/articles/s41380-024-02521-9
<![CDATA[Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension]]> https://www.nature.com/articles/s41380-024-02478-9 Molecular Psychiatry, Published online: 25 March 2024; doi:10.1038/s41380-024-02478-9

Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension]]>
Sanne Y. Smith-ApeldoornJolien K. E. VeraartJeanine KamphuisJan SpijkerAnnemarie van der MeijAntoinette D. I. van AsseltMarije aan het RotRobert A. Schoevers doi:10.1038/s41380-024-02478-9 Molecular Psychiatry, Published online: 2024-03-25; | doi:10.1038/s41380-024-02478-9 2024-03-25 Molecular Psychiatry 10.1038/s41380-024-02478-9 https://www.nature.com/articles/s41380-024-02478-9
<![CDATA[Resting state functional connectivity modifications in monoaminergic circuits underpin fatigue development in patients with multiple sclerosis]]> https://www.nature.com/articles/s41380-024-02532-6 Molecular Psychiatry, Published online: 25 March 2024; doi:10.1038/s41380-024-02532-6

Resting state functional connectivity modifications in monoaminergic circuits underpin fatigue development in patients with multiple sclerosis]]>
Monica MargoniPaola ValsasinaAnna BacchettiDamiano MistriPaolo PreziosaMaria A. RoccaMassimo Filippi doi:10.1038/s41380-024-02532-6 Molecular Psychiatry, Published online: 2024-03-25; | doi:10.1038/s41380-024-02532-6 2024-03-25 Molecular Psychiatry 10.1038/s41380-024-02532-6 https://www.nature.com/articles/s41380-024-02532-6